作者:Romain Noel、Xinyi Song、Youseung Shin、Subhashis Banerjee、Douglas Kojetin、Li Lin、Claudia H. Ruiz、Michael D. Cameron、Thomas P. Burris、Theodore M. Kamenecka
DOI:10.1016/j.bmcl.2012.04.023
日期:2012.6
The design and synthesis of a novel series of Rev-erb alpha agonists is described. The development and optimization of the tetrahydroisoquinoline series was carried out from an earlier acyclic series of Rev-erb alpha agonists. Through the optimization of the scaffold 1, several potent compounds with good in vivo profiles were discovered. (C) 2012 Elsevier Ltd. All rights reserved.